使用机器人外骨进行运动可以通过促进渐进式运动强度来改善帕金森病患者的记忆和步态
Chris A McGibbon1,2, Andrew Sexton3, Pearl Gryfe4
1Institute of Biomedical Engineering, University of New Brunswick, 25 Dineen Dr, Fredericton, NB, E3B 5A3, Canada. cmcgibb@unb.ca.
Scientific reports
|February 22, 2024
概括
使用外骨架进行逐步高强度运动,改善了帕金森病患者的记忆力和步态. 这种先进的康复技术促进了持续的运动强度,与传统方法不同.
科学领域:
- 神经学 神经学
- 康复技术 康复技术 康复技术
- 运动生理学 运动生理学
背景情况:
- 帕金森病 (PD) 影响运动控制和认知功能.
- 高强度运动可能对患有帕金森病 (PwPD) 的个体有好处,但机制尚不清楚.
- 下肢外骨架可能有助于在PwPD中进行渐进式运动.
研究的目的:
- 探索PwPD中运动强度进展和记忆/步态结果之间的关系.
- 为了比较运动强度的进展与没有动力外骨.
- 调查高级康复技术在PD运动干预中的作用.
主要方法:
- 试点随机对照试验与27名PwPD (50-85岁) 进行.
- 干预:每周两次进行8周的渐进式运动,使用 (Exo) 或不使用 (Nxo) 下肢外骨架.
- 结果测量:活动计数*min−1 (ACPM),SCOPA-COG记忆量表,步行耐力6分钟步行测试 (6MWT).
主要成果:
- 在8周内,Exo组逐渐增加了ACPM;Nxo组在4周后停滞不前.
- 运动强度的进展与记忆力 (SCOPA-COG) 和步行耐力 (6MWT) 的改善相关.
- 通过外骨架技术促进的持续高强度运动与更好的结果有关.
结论:
- 使用外骨促进高强度运动可以改善PwPD患者的记忆力和步行耐力.
- 在神经退行性疾病中,先进的康复技术可能对最大限度地提高运动效益至关重要.
- 血管新生和神经营养机制是运动诱导PwPD改善的潜在途径.
更多相关视频
04:49Author Spotlight: Enhancing Post-Stroke Upper Limb Rehabilitation with Robotic Technologies for Improved Motor Recovery and Functional Outcomes
Published on: September 6, 2024
743
05:54A Rehabilitation Program of Exoskeleton-assisted Body Weight-Supported Treadmill Training with Non-immersive Virtual Reality for Stroke Patients
Published on: May 16, 2025
173
相关概念视频
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...